Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Pharmacol Res. 2017 Aug 18;128:73–79. doi: 10.1016/j.phrs.2017.08.007

Table 1.

Differentially expressed miRNAs and their molecular target(s) in OA

miRNA Differential expression in OA Target gene(s) Biological effects References
miR-22 Upregulated PPARα, BMP7, ACAN Lipid metabolism [29]
miR-9 Upregulated MMP-13, MCPIP1 Matrix degradation [30] [31]
miR-25 Upregulated COX-2 Inflammation [30] [32]
miR-602 Upregulated SHH Chondrocytes homeostasis [33]
miR-608 Upregulated SHH Chondrocytes homeostasis [33]
miR-139 Upregulated MCPIP1 Inflammation [31]
miR-27a Downregulated MMP-13, IGFBP5 Matrix degradation [34]
miR-27b Downregulated MMP-13 Matrix degradation [35]
miR-140 Downregulated ADAMTS-5, MMP-13 Matrix degradation [36]
miR199a Downregulated COX-2 Inflammation [35]
miR-138 Downregulated Sp1, HIF2α Chondrocytes differentiation [37]
[38]
HHS Vulnerability Disclosure